Correlation Between Cognition Therapeutics and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognition Therapeutics and Immix Biopharma, you can compare the effects of market volatilities on Cognition Therapeutics and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Immix Biopharma.
Diversification Opportunities for Cognition Therapeutics and Immix Biopharma
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Cognition and Immix is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Immix Biopharma go up and down completely randomly.
Pair Corralation between Cognition Therapeutics and Immix Biopharma
Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Immix Biopharma. In addition to that, Cognition Therapeutics is 1.31 times more volatile than Immix Biopharma. It trades about -0.14 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.09 per unit of volatility. If you would invest 168.00 in Immix Biopharma on August 27, 2024 and sell it today you would earn a total of 11.00 from holding Immix Biopharma or generate 6.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognition Therapeutics vs. Immix Biopharma
Performance |
| Timeline |
| Cognition Therapeutics |
| Immix Biopharma |
Cognition Therapeutics and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognition Therapeutics and Immix Biopharma
The main advantage of trading using opposite Cognition Therapeutics and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Cognition Therapeutics vs. Reviva Pharmaceuticals Holdings | Cognition Therapeutics vs. Eyenovia | Cognition Therapeutics vs. Transcode Therapeutics | Cognition Therapeutics vs. Kodiak Sciences |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |